Adjuvant Therapy Following Resection of Gastroenteropancreatic Neuroendocrine Tumors Provides no Recurrence or Survival Benefit

BACKGROUND AND OBJECTIVES: Lack of high-level evidence supporting adjuvant therapy for patients with resected gastroenteropancreatic neuroendocrine tumors (GEP NETs) warrants evaluation of its non-standard of care use. METHODS: Patients with primary GEP NETs who underwent curative-intent resection a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Surg Oncol
Päätekijät: Barrett, James R, Rendell, Victoria, Pokrzywa, Courtney, Lopez-Aguiar, Alexandra G, Cannon, John, Poultsides, George A, Rocha, Flavio, Crown, Angelena, Beal, Eliza, Pawlik, Timothy Michael, Fields, Ryan, Panni, Roheena Z, Smith, Paula, Idrees, Kamran, Cho, Clifford, Beems, Megan, Maithel, Shishir, Weber, Sharon, Abbott, Daniel Erik
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279693/
https://ncbi.nlm.nih.gov/pubmed/32153032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.25896
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia